# EDGAR Filing Document

**Accession Number:** 0001754195
**File Stem:** 0001754195-26-000053
**Filing Date:** 2026-6
**Character Count:** 2160
**Document Hash:** 68bf6fa740d3c78141db2d6f5da1df0d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001754195-26-000053.hdr.sgml**: 20260625

**ACCESSION NUMBER**: 0001754195-26-000053

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260625

**DATE AS OF CHANGE**: 20260625

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Trulieve Cannabis Corp.
- **CENTRAL INDEX KEY:** 0001754195
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 581882476
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43338
- **FILM NUMBER:** 261122990

**BUSINESS ADDRESS:**
- **STREET 1:** 3494 MARTIN HURST ROAD
- **CITY:** TALLAHASSEE
- **STATE:** FL
- **ZIP:** 32312
- **BUSINESS PHONE:** 8502988866

**MAIL ADDRESS:**
- **STREET 1:** 3494 MARTIN HURST ROAD
- **CITY:** TALLAHASSEE
- **STATE:** FL
- **ZIP:** 32312

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

____________________

**SCHEDULE 14A**

**Proxy Statement Pursuant to Section 14(a) of the** 

**Securities Exchange Act of 1934** 

**(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;)**

____________________

Filed by the Registrant ⌧

Filed by a Party other than the Registrant □

Check the appropriate box:

□ Preliminary Proxy Statement

□ **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))**

□ Definitive Proxy Statement

⌧ Definitive Additional Materials

□ Soliciting Material under §240.14a-12

**TRULIEVE CANNABIS CORP.**

**(Name of Registrant as Specified In Its Charter)** 

**(Name of Person(s) Filing Proxy Statement, if other than the Registrant)** 

Payment of Filing Fee (Check the appropriate box):

⌧ No fee required.

□ Fee paid previously with preliminary materials.

□ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

------

![a2026specialmeetingnoticeab.jpg](a2026specialmeetingnoticeab.jpg)

------

![a2026specialmeetingnoticeac.jpg](a2026specialmeetingnoticeac.jpg)

<br>